TAMMY WILLIAMS: Open Payments
NPI 1932870136 · SAMSON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 18 payments from 5 companies in 2025. Trend: 2023 $247 · 2024 $323 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $170 |
| Novo Nordisk Inc | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| ABBVIE INC. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: MOUNJARO, CAPLYTA, Wegovy, Ozempic, Rybelsus, VRAYLAR, ZEPBOUND, Tirosint.
Industry payments across AL — which companies pay providers there.
